Virginie Naël

523 total citations
12 papers, 201 citations indexed

About

Virginie Naël is a scholar working on Epidemiology, Radiology, Nuclear Medicine and Imaging and Psychiatry and Mental health. According to data from OpenAlex, Virginie Naël has authored 12 papers receiving a total of 201 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 3 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Psychiatry and Mental health. Recurrent topics in Virginie Naël's work include Ophthalmology and Visual Impairment Studies (5 papers), Retinal Imaging and Analysis (3 papers) and Dementia and Cognitive Impairment Research (3 papers). Virginie Naël is often cited by papers focused on Ophthalmology and Visual Impairment Studies (5 papers), Retinal Imaging and Analysis (3 papers) and Dementia and Cognitive Impairment Research (3 papers). Virginie Naël collaborates with scholars based in France, Australia and Germany. Virginie Naël's co-authors include Cécile Delcourt, Isabelle Carrière, Catherine Helmer, Christophe Tzourio, Karine Pérès, Angelo Arleo, Vincent Daïen, Hélène Amieva, Claudine Berr and Luc Letenneur and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Public Health and Journal of Affective Disorders.

In The Last Decade

Virginie Naël

12 papers receiving 197 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Virginie Naël France 7 100 61 52 32 27 12 201
Olivia J. Killeen United States 13 56 0.6× 107 1.8× 59 1.1× 55 1.7× 12 0.4× 29 268
Phoebe A. Lamuda United States 9 108 1.1× 60 1.0× 42 0.8× 19 0.6× 3 0.1× 24 232
Jerome Ip Australia 7 168 1.7× 136 2.2× 146 2.8× 23 0.7× 45 1.7× 9 388
David Herrick United Kingdom 9 75 0.8× 33 0.5× 22 0.4× 34 1.1× 24 0.9× 12 348
Joseph W. Fink United States 10 217 2.2× 45 0.7× 10 0.2× 54 1.7× 29 1.1× 19 377
Anthea Cochrane Australia 8 271 2.7× 250 4.1× 115 2.2× 67 2.1× 11 0.4× 20 418
Esra Güney Türkiye 10 28 0.3× 80 1.3× 39 0.8× 4 0.1× 22 0.8× 42 293
Wai Kent Yeung United Kingdom 7 30 0.3× 32 0.5× 20 0.4× 81 2.5× 51 1.9× 10 192
Stephanie E. Eonta United States 6 245 2.5× 15 0.2× 20 0.4× 23 0.7× 8 0.3× 7 328
Rosario Sánchez United States 8 426 4.3× 541 8.9× 370 7.1× 38 1.2× 5 0.2× 9 765

Countries citing papers authored by Virginie Naël

Since Specialization
Citations

This map shows the geographic impact of Virginie Naël's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginie Naël with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginie Naël more than expected).

Fields of papers citing papers by Virginie Naël

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginie Naël. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginie Naël. The network helps show where Virginie Naël may publish in the future.

Co-authorship network of co-authors of Virginie Naël

This figure shows the co-authorship network connecting the top 25 collaborators of Virginie Naël. A scholar is included among the top collaborators of Virginie Naël based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginie Naël. Virginie Naël is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Roussel, Murielle, et al.. (2024). Effectiveness and safety of belantamab mafodotin in patients with relapsed or refractory multiple myeloma in real‐world setting: The ALFA study. European Journal Of Haematology. 113(3). 310–320. 3 indexed citations
2.
Moussaoui, Sohela, Pierre Chauvin, Gladys Ibanez, et al.. (2022). Construction and Validation of an Individual Deprivation Index: a Study Based on a Representative Cohort of the Paris Metropolitan Area. Journal of Urban Health. 99(6). 1170–1182. 4 indexed citations
3.
Maller, Jerome J., et al.. (2022). Association Between Vision and Brain Cortical Thickness in a Community-Dwelling Elderly Cohort. SHILAP Revista de lepidopterología. Volume 14. 71–82. 2 indexed citations
4.
Naël, Virginie, Karine Pérès, Jean‐François Dartigues, et al.. (2019). Vision loss and 12-year risk of dementia in older adults: the 3C cohort study. European Journal of Epidemiology. 34(2). 141–152. 62 indexed citations
5.
Cosh, Suzanne, Virginie Naël, Isabelle Carrière, et al.. (2018). Bidirectional associations of vision and hearing loss with anxiety: prospective findings from the Three-City Study. Age and Ageing. 47(4). 582–589. 15 indexed citations
6.
Naël, Virginie, Audrey Cougnard‐Grégoire, Angelo Arleo, et al.. (2018). Prevalence and Associated Factors of Uncorrected Refractive Error in Older Adults in a Population-Based Study in France. JAMA Ophthalmology. 137(1). 3–3. 17 indexed citations
7.
Cosh, Suzanne, Isabelle Carrière, Virginie Naël, et al.. (2018). The association of vision loss and dimensions of depression over 12 years in older adults: Findings from the Three City study. Journal of Affective Disorders. 243. 477–484. 16 indexed citations
8.
Naël, Virginie, Karine Pérès, Angelo Arleo, et al.. (2018). P3‐596: VISUAL LOSS AND COGNITIVE DECLINE IN OLDER ADULTS: RESULTS FROM A FRENCH POPULATION‐BASED COHORT STUDY. Alzheimer s & Dementia. 14(7S_Part_25). 3 indexed citations
9.
Naël, Virginie, Karine Pérès, Isabelle Carrière, et al.. (2017). Visual Impairment, Undercorrected Refractive Errors, and Activity Limitations in Older Adults: Findings From the Three-City Alienor Study. Investigative Ophthalmology & Visual Science. 58(4). 2359–2359. 18 indexed citations
10.
Pérès, Karine, Fanny Matharan, Vincent Daïen, et al.. (2017). Visual Loss and Subsequent Activity Limitations in the Elderly: The French Three-City Cohort. American Journal of Public Health. 107(4). 564–569. 47 indexed citations
11.
Sotto, Albert, Marie Audrain, David Boutoille, et al.. (2014). Use of interferon gamma release assays in clinical practice: Review of QuantiFERON-TB prescription in a French university hospital. Scandinavian Journal of Infectious Diseases. 46(5). 392–396. 2 indexed citations
12.
Nienhaus, Albert, et al.. (2013). The effect of introducing IGRA to screen French healthcare workers for tuberculosis and potential conclusions for the work organisation. Journal of Occupational Medicine and Toxicology. 8(1). 12–12. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olivia J. Killeen Breakdown of academic impact, for papers by Phoebe A. Lamuda Breakdown of academic impact, for papers by Jerome Ip Breakdown of academic impact, for papers by David Herrick Breakdown of academic impact, for papers by Joseph W. Fink Breakdown of academic impact, for papers by Anthea Cochrane Breakdown of academic impact, for papers by Esra Güney Breakdown of academic impact, for papers by Wai Kent Yeung Breakdown of academic impact, for papers by Stephanie E. Eonta Breakdown of academic impact, for papers by Rosario Sánchez
Rankless by CCL
2026